Comparative effect of nitroglycerin and misoprostol on cervical ripening before hysteroscopy
Phase 3
Recruiting
- Conditions
- Cervical ripening before hysteroscopy.
- Registration Number
- IRCT20220203053929N1
- Lead Sponsor
- Iran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 84
Inclusion Criteria
: Conscious patient satisfaction, hysteroscopic women, lack of nitroglycerin sensitivity, without cardiovascular disease lack of existence of severe bleeding, as well as unstable status
Exclusion Criteria
Systolic blood pressure less than ?100 mm Hg, intravascular volume reduction, valvular heart disease, severe bleeding, multiparous (NVD 2 = Gravid,) impossibility of using nitroglycerin based on anesthesiologist's sensitivity to any food preservative) Use of hypertension or cardiac drugs for cerebral hemorrhage, anemia, glaucoma, hyperthyroidism, heart problems, heart failure, liver and kidney disease, hypotension and dissatisfaction with continuing the company
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Cervical ripening, bleeding measurment, gravidity, parity, abortion number andside Effects like vomiting, hypotension, dizziness, stomach pain, diarehea, fever. Timepoint: Before hysteroscopy and after using Medicine ?and Side Effects after using. Method of measurement: Cervical dilation with measured dilator, bleeding Mount :pad percentage, pain score, weight :kg, gravidity :pregnancy count/parity:living birth delivery, sideeffect like diarehea, flushinv, hypotension, dizziness, headache, fever, nausea ??? vomiting.
- Secondary Outcome Measures
Name Time Method Pain score and Mount of bleeding and dilation after hysteroscopy. Timepoint: Before hysteroscopy and after medications. Method of measurement: Pad percentage, pain score? measurment of dilation with measured dilator bouji.